Citation Impact
Citing Papers
Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
2008
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Origins of catalysis by computationally designed retroaldolase enzymes
2010 StandoutNobel
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
2009
The use of mRNA display to select high-affinity protein-binding peptides
2001 StandoutNobel
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
1999
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
2016
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
2011
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility
2010
Selection and evolution of enzymes from a partially randomized non-catalytic scaffold
2007 StandoutNatureNobel
Role of wnts in prostate cancer bone metastases
2005
Cancer to bone: a fatal attraction
2011 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Combinatorial and computational challenges for biocatalyst design
2001 StandoutNatureNobel
Cancer Metastasis: Building a Framework
2006 Standout
Computational Enzyme Design
2013 StandoutNobel
Surviving at a Distance: Organ-Specific Metastasis
2015
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
2008
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
2005
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The road to fully programmable protein catalysis
2022 StandoutNatureNobel
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
2005
Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis
2017
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
2013
Principles for designing ideal protein structures
2012 StandoutNatureNobel
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
2009
TRPM8 ion channel ligands for new therapeutic applications and as probes to study menthol pharmacology
2012
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
The development of androgen-independent prostate cancer
2001 Standout
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
2010
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
2001
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Prognostic significance of nemo-like kinase in nasopharyngeal carcinoma
2014
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins
2003
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Glycoproteomic Analysis of Prostate Cancer Tissues by SWATH Mass Spectrometry Discovers N-acylethanolamine Acid Amidase and Protein Tyrosine Kinase 7 as Signatures for Tumor Aggressiveness
2014
Kemp elimination catalysts by computational enzyme design
2008 StandoutNatureNobel
Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer
2013
Emerging Biological Principles of Metastasis
2017 Standout
Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
2008
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Targeting metastasis
2016
TGFβ in Cancer
2008 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
DNA enzymes
1997
Bone metastasis: the importance of the neighbourhood
2016
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Man-made enzymes — from design to in vitro compartmentalisation
2000
Targeting prostate cancer angiogenesis through metastasis‐associated protein 1 (MTA1)
2010
Tumour necrosis factor and cancer
2009
Exploring protein fitness landscapes by directed evolution
2009 StandoutNobel
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
2007
Metastatic colonization by circulating tumour cells
2016 StandoutNature
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
2004
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Bisphosphonate conjugation for bone specific drug targeting
2018
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
In vitro selection and evolution of proteins
2001
Osteoblasts in prostate cancer metastasis to bone
2005
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
2005
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.
1999
Preoperative Plasma Levels of Transforming Growth Factor Beta1 (TGF-β1) Strongly Predict Progression in Patients Undergoing Radical Prostatectomy
2001
RNA-peptide fusions for the in vitro selection of peptides and proteins
1997 StandoutNobel
Rational design of nascent metalloenzymes
2000
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
Computational protein engineering
1998
Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient
2005
Bone Morphogenetic Protein-6 Promotes Osteoblastic Prostate Cancer Bone Metastases through a Dual Mechanism
2005
Cell–cell interaction in prostate gene regulation and cytodifferentiation
1997
Wnt proteins synergize to activate β-catenin signaling
2017
Enzyme-like proteins by computational design
2001
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Progress in Modeling of Protein Structures and Interactions
2005 StandoutScienceNobel
Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton
2005
Control of stem cell self-renewal and differentiation by the heterochronic genes and the cellular asymmetry machinery in Caenorhabditis elegans
2015 StandoutNobel
Catalytic Cyclophanes. Part XI. A flavo‐thiazolio‐cyclophane as a biomimetic catalyst for the preparative‐scale electro‐oxidation of aromatic aldehydes to methyl esters
1997
Catalytic Mechanism and Performance of Computationally Designed Enzymes for Kemp Elimination
2008 StandoutNobel
Detection and characterization of carcinoma cells in the blood
1998
Rational Design of a Calcium-Binding Protein
2003
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
2003
De Novo Computational Design of Retro-Aldol Enzymes
2008 StandoutScienceNobel
Ribosome display efficiently selects and evolves high-affinity antibodiesin vitrofrom immune libraries
1998
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases
2008
Protein topology and stability define the space of allowed sequences
2002 StandoutNobel
Novel strategies and therapeutics for the treatment of prostate carcinoma
2000
Molecular Biology of Bone Metastasis
2007
Emerging role of extracellular vesicles in mediating cancer cachexia
2018
Structural insights into TRPM8 inhibition and desensitization
2019 StandoutScienceNobel
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Chemical Glycoproteomics
2016 StandoutNobel
In Vitro Selection of Catalytic Polynucleotides
1997
Works of Eva Corey being referenced
Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
2013
Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment
2010
The expression of osteoclastogenesis‐associated factors and osteoblast response to osteolytic prostate cancer cells
2009
Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells
2002
Elevation of cytokine levels in cachectic patients with prostate carcinoma
2003
LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen
1998
Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function
2003
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
2007
Identification of differentially expressed prostate genes: Increased expression of transcription factor ETS-2 in prostate cancer
1997
Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) Messages
1997
The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft
2004
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
2009
LuCaP 35: A new model of prostate cancer progression to androgen independence
2003
Inhibition of angiopoietin‐2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability
2010
Histological, Immunophenotypic and Histomorphometric Characterization of Prostate Cancer Bone Metastases
2004
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases
2007
Nemo‐like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells
2009
Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspects
1998
High-Affinity Peptide Ligands to Prostate-Specific Antigen Identified by Polysome Selection
1997
Osteoprotegerin and rank ligand expression in prostate cancer
2001
Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration
1996
Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.
1997
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
2013
On the failure of de novo-designed peptides as biocatalysts.
1996
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression
2003
LNCaP produces both putative zymogen and inactive, free form of prostate‐specific antigen
1998
Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.
2001
Osteoprotegerin in Prostate Cancer Bone Metastasis
2005
Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis
2006
Improved reverse transcriptase–polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow
1997
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
2003
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
2011
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
2006